Personal antibiotic resistance.
A 42-year-old woman presents to you with a 5-day history of nonproductive cough, postnasal drainage, and sore throat. She denies fevers, shortness of breath, or headache. She received amoxicillin 2 weeks ago for similar symptoms, and although she improved, she feels that she has not completely recovered. On examination she is afebrile and her head and neck, lymph node, and lung exams are normal. You deliver your speech about antibiotic resistance and how important it is to use antibiotics only when absolutely necessary. She becomes quite irritated. You acquiesce by offering her a delayed antibiotic prescription for azithromycin. You inform her not to take it unless she develops fever, shortness of breath, or increased cough. You also ask her to inform the nurse if she starts the antibiotic. You once again berate yourself for "caving." You also wonder what the evidence is for her personally being resistant to amoxicillin because of the first course of antibiotics she received.
In patients receiving antibiotics in primary care, what is the evidence for personal antibiotic resistance, and how long does it last?
You open PubMed (www.pubmed.gov) and enter "antibiotic resistance" AND "primary care." You find a relevant study. (See box at right.)
This systematic review was well conceived and has broad application to primary care. The search was thorough, and methods of abstraction and quality assessment were standard. What is most striking about this study is that it provides overwhelming evidence for antibiotic resistance in our individual patients after antibiotic treatment, rather than within the abstract concept of "the community." Resistance can be transferred from commensal and pathogenic organisms so that even if the pathogen is eradicated, new pathogens can pick up resistance from the remaining nonpathogenic bacteria. This information should be provided to patients who, when ill, may not be concerned about antibiotic resistance at the population level but who may be more influenced by hearing about possible increased difficulty with their own treatment if they "really get sick."
The patient calls the next day to tell the nurse that she started the antibiotic because she was not getting any better. You work on your antibiotic speech to make it more convincing for the next patient.
Costelloe C., et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ 2010;340:c2096.
* Criteria for study inclusion: Studies were eligible for inclusion if they investigated the relationship between antibiotics prescribed in primary care and antimicrobial resistance in bacteria sampled from any body site, were observational and experimental, and were analyzed at the level of the individual.
* Study identification: Investigators searched MEDLINE (1955 to May 2009), EMBASE (1980 to May 2009), Cochrane databases, and the ISI Web of Knowledge.
* Data extraction and quality assessment: Full articles were reviewed independently by two reviewers who extracted study data and assessed study quality.
* Outcomes: Outcomes included bacteria type, sampling location, antibiotics to which resistance was measured, and the method of measuring resistance. The outcome measure was the odds ratio (OR) of resistance among participants exposed to antibiotics, compared with those who were not exposed. ORs were tabulated by bacterium type and sampling location and by time since antibiotic exposure.
* Results: Twenty-four papers were included in the review, including 5 randomized controlled trials and 19 observational studies (2 prospective, 17 controlled observational or case-control). Twenty-two studies sampled bacteria from patients with urinary tract infection, upper respiratory infection, otitis media, chronic obstructive pulmonary disease, methicillin-resistant Staphylococcus aureus (MRSA), or trachoma; two studies were conducted in healthy adult volunteers. A wide variety of antibiotics were given 2-104 weeks before measurement of antibiotic resistance. For the five studies of urinary tract bacteria including more than 14,000 subjects, the ORs for resistance were 2.5 (95% CI: 1-2.9) within 2 months of antibiotic treatment and 1.33 (95% CI: 1.2-1.5) within 12 months. For the seven studies of respiratory tract infections including more than 2,600 patients, the ORs were 2.4 (95% CI: 1.4-3.9) within 2 months and 2.4 (95% CI: 1.3-4.5) within 12 months. Antibiotic resistance changed over time from 12.2 (95% CI: 6.8-22.1) at 1 week to 6.1 (95% CI: 2.8-13.4) at 1 month, 3.6 (95% CI: 2.2-6.0) at 2 months, and 2.2 (95% CI: 1.3-3.6) at 6 months. Longer durations and multiple courses were linked to higher resistance rates. One study found a link between MRSA and the prescription of an antibiotic in the previous 0-6 months (OR 3.1; 95% CI: 1.1-8.6).
BY JON O. EBBERT, M.D., AND ERIC G. TANGALOS, M.D.
DR. EBBERT and DR. TANGALOS are with the Mayo Clinic in Rochester. Minn. They report having no conflicts of interest. To respond to this column or suggest topics for consideration, write to Dr. Ebbert and Dr. Tangalos at our editorial offices or e-mail them at email@example.com.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||MINDFUL PRACTICE|
|Author:||Ebbert, Jon O.; Tangalos, Eric G.|
|Publication:||Internal Medicine News|
|Date:||Jul 1, 2010|
|Previous Article:||Excess risk of GBS low with H1N1 vaccine.|
|Next Article:||Antivirals blunted flu complications.|